Part D Formulary Negotiations Take “Portfolio Approach” For AstraZeneca
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca has adopted a "portfolio approach" in its negotiations with prescription drug plans to gain strong Medicare Part D formulary positions, Chief Financial Officer Jonathan Symonds said